May 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.26 billion in 2025, with a CAGR of 5.02%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
May 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 9.40 billion in 2025 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
May 2026
The global Parkinsons disease biomarkers market size was evaluated at USD 1.35 billion in 2025 and is predicted to hit around USD 4.88 billion by 2035, growing at a CAGR of 13.80%.
April 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
April 2026
The global inflammatory disease market size was evaluated at USD 125.00 billion in 2025 and is predicted to hit around USD 241.34 billion by 2035, growing at a CAGR of 6.80%.
April 2026
The global enteric disease testing market size was evaluated at USD 4.30 billion in 2025 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
March 2026
The global periodontal disease treatment market size was evaluated at USD 2.94 billion in 2025 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
March 2026
The global infectious disease immunoassay market size was evaluated at USD 2.88 billion in 2025 and is predicted to hit around USD 8.87 billion by 2035, growing at a CAGR of 11.90%.
March 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 35.39 billion in 2025 with a CAGR of 7.22%.
February 2026
The global foot and mouth disease vaccine market size is expected to reach around USD 3.48 billion by 2035 from USD 1.94 billion in 2025 with a CAGR of 6.02%.
February 2026
The global respiratory disease vaccine market size was calculated at USD 101.10 billion in 2025 and is projected to hit around USD 123.77 billion by 2035 with a CAGR of 2.04%.
January 2026
The global fabry disease treatment market size reached USD 2.45 billion in 2025 and is estimated to hit around USD 5.20 billion by 2035 with a CAGR of 7.82%.
January 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.02 billion in 2025 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
January 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.10 billion in 2025 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
January 2026
The global end stage renal disease market size was estimated at USD 153.72 billion in 2025 and is predicted to hit around USD 531.76 billion by 2035 with a CAGR of 13.21%.
January 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
December 2025
The predictive disease analytics market size reached USD 4.97 billion in 2025 and is expected to be worth around USD 23.08 billion by 2035 with a CAGR of 16.6%.
December 2025
The lung disease therapeutics market size was estimated at USD 96.82 billion in 2025 and is expected to hit over USD 173.48 billion by 2035 with a CAGR of 6.01%.
December 2025
The chronic obstructive pulmonary disease treatment market size is expected to hit around USD 33.03 billion by 2035 from USD 21.04 billion in 2025 at a CAGR of 5.14%.
December 2025
The lyme disease diagnostic devices market size accounted for USD 2.82 billion in 2025 and is predicted to hit around USD 4.79 billion by 2035, with a CAGR of 5.44%.
December 2025
The infectious respiratory disease diagnostics market size is projected to hit around USD 91.91 billion by 2034 from USD 57.55 billion in 2025 with a CAGR of 5.34%.
November 2025
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 11.43 billion in 2025, with a CAGR of 7.24%.
November 2025
The global sickle cell disease treatment market size is predicted to hit around USD 14.06 billion by 2034 from USD 3.75 billion in 2025 with a CAGR of 15.81%.
November 2025
The infectious disease therapeutics market size is calculated at USD 36.22 billion in 2025 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
November 2025
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,182.74 million by 2034, growing at a CAGR of 12.04%.
October 2025
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 4.72 billion by 2034 increasing from USD 1.70 billion in 2025, with a CAGR of 12.00%.
October 2025
The global disease management apps market size is calculated at USD 10.20 billion in 2025 and is projected to hit around USD 24.69 billion by 2034 with a CAGR of 10.32%.
September 2025
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
September 2025
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com